The study participant is being asked to take part in this research study because the participant has been diagnosed with neuroblastoma that did not fully respo…

Neuroblastoma Recurrent

~Estimated

~$10 – $6,250

St. Jude Children's Research HospitalNCT07085338

Phase 1

Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma

This research is being done to investigate a treatment regimen of Irinotecan, Temozolomide, and Sargramostin, and an immunotherapy called Naxitamab and whether…

NeuroblastomaNeuroblastoma RecurrentRelapsed Neuroblastoma+1 more

~Estimated

~$10 – $7,500

Steven DuBois, MDNCT07027748